Detalles de la búsqueda
1.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738257
2.
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.
Rheumatology (Oxford)
; 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698987
3.
A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitis.
J Eur Acad Dermatol Venereol
; 37(5): 1046-1055, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606551
4.
Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app.
Rheumatology (Oxford)
; 61(12): 4845-4854, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274670
5.
Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13â391 real-world patients.
Rheumatology (Oxford)
; 61(10): 3919-3929, 2022 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35108380
6.
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering.
Rheumatology (Oxford)
; 61(6): 2398-2412, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636846
7.
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Ann Rheum Dis
; 80(11): 1400-1409, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926921
8.
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Rheumatology (Oxford)
; 60(8): 3635-3645, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367900
9.
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Rheumatology (Oxford)
; 60(12): 5549-5559, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748831
10.
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.
Rheumatology (Oxford)
; 60(1): 380-391, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929463
11.
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis.
Rheumatology (Oxford)
; 60(SI): SI3-SI12, 2021 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34146099
12.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31960053
13.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31665497
14.
Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
Ann Rheum Dis
; 78(3): 320-327, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30612115
15.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396903
16.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31431486
17.
Remotely collected patient-reported data characterises the impact of idiopathic inflammatory myopathy flares upon work productivity.
Rheumatology (Oxford)
; 63(6): e168-e169, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38141204
18.
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
JAMA
; 321(5): 461-472, 2019 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30721294
19.
Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?
Ann Rheum Dis
; 77(12): 1736-1741, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30237203
20.
The EuroMyositis registry: an international collaborative tool to facilitate myositis research.
Ann Rheum Dis
; 77(1): 30-39, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28855174